Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5001578 | 0.85 | XPO1 (0.48) | XPO1 | |
| SCHEMBL4997703 | 0.83 | XPO1 (0.50) | XPO1PDE2A | |
| SCHEMBL4992537 | 0.82 | XPO1 (0.68) | XPO1 | |
| SCHEMBL4997647 | 0.82 | XPO1 (0.48) | XPO1PDE2A | |
| SCHEMBL5001382 | 0.79 | XPO1 (0.46) | XPO1 | |
| SCHEMBL1592934 | 0.78 | XPO1 (0.54) | XPO1 | |
| SCHEMBL3632724 | 0.77 | XPO1 (0.52) | XPO1 | |
| SCHEMBL1592466 | 0.77 | XPO1 (0.57) | XPO1 | |
| SCHEMBL1592513 | 0.76 | XPO1 (0.60) | XPO1 | |
| SCHEMBL4995602 | 0.75 | XPO1 (0.54) | XPO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080275057-A1 | Compounds with anti-cancer activity | CANBAS CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275057-A1 | Compounds with anti-cancer activity | CDKN1A, CDC25C, DDB1 | XPO1 280/4885PDE2A 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.